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pathomechanism?
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Abstract 
Hypersensitivity to para-phenylenediamine (PPD) and related compounds induced by temporary black henna tattoos 
has become a serious health problem worldwide. Different patterns of sensitization with various clinical aspects are 
described in literature due to PPD associated to henna tattoo and these manifestations are likely correlated with the 
immunological and dermatological pathomechanisms involved. Henna is the Persian name of the plant Lawsonia iner-
mis, Fam. Lythraceae. It is a woody shrub that grow in regions of North Africa, South Asia, India and Sri Lanka. Nowa-
days it is rather frequent to see temporary “tattoos” performed with henna. To make tattoos darker and long-lasting 
PPD has been associated to henna in tattoo drawings mixtures, so obtaining “black henna”. In these years there has 
been a rise of contact sensitization to PPD and in medical literature an increased number of cases have been reported 
on temporary henna tattoo application. Here we review the various clinical patterns related to PPD and henna tat-
too, to investigate the possible link between clinic-morphological pictures and the immunological response to PPD 
and henna. The literature underlines that different clinical manifestations are related to black henna containing PPD, 
and its derivative products may cause delayed-type as well as immediate-type reactions. Further studies are needed 
to investigate the relationship between clinical and morphological aspects of PPD contact dermatitis and the T cell 
subsets predominance.
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Background
The term “tattoo” derives from two Polynesians words, 
“TA”, which means “to draw” and “TOO” or “TAU” which 
means “spirit”. The whole word means “draw the body”. 
The tattooing procedures have been quite variable in dif-
ferent ages, depending on the cultures involved and thus 
influencing the perception of a positive or a negative sig-
nificance. The Hebrews follow Torah exhortations (“you 
won’t make any incision on your body”, Deuteronomy, 14 
but also Leviticus, 19:28) while for the Maoris the tattoo 
drawings on the face indicate the social class and status, 
the profession, the clan and the ability in a battle [1].
Nowadays, in a “liquid society” [2], where nothing is 
forever, it has become rather frequent to see temporary 
“tattoos” performed with henna. Painless, highly decora-
tive and, above all, temporary, the henna colour lasts for 
up to 3  weeks, making it is the perfect way of creating 
a fashionable look while avoiding the consequences or 
risks connected to a permanent tattoo.
Henna is the Persian name of the plant Lawsonia 
inermis, Fam. Lythraceae. It is a woody shrub, reaching 
heights up to 3 metres, which grows up mainly in the 
warm, moist regions of North Africa, South Asia, India 
Open Access
Clinical and Molecular Allergy
*Correspondence:  ambulatorio.allergologia@uniba.it 
6 Section of Allergy and Clinical Immunology, Department of Internal 
Medicine and Infectious Diseases, University of Bari Medical School, Bari, 
Italy
Full list of author information is available at the end of the article
Page 2 of 6Calogiuri et al. Clin Mol Allergy  (2017) 15:8 
and Sri Lanka. Henna plant was identified by Linnaeus, 
who called it with that name to honour the Scottish doc-
tor of his scientific expedition, Isaac Lawson. The active 
dying ingredient of henna is a naphtoquinone called 
lawsone (2-hydroxy-1,4-naphthoquinone), constituting 
about 1% by weight of the crushed leaves [3].
Commercially, henna is available as a green powder, 
obtained from crushing dried leaves mixed with water 
and oil to create a paste. Natural henna gives a brown-
ish-orange pigment to the skin when applied (red henna), 
but the colour will darken to brown. Various substances, 
such as lemon oil, vinegar, eucalyptus oil and coffee, 
may be added to obtain different colouring effects and a 
thick paste [4]. The henna is left on the skin to dry for 
at least 2 h and preferably up to 24 h. The longer henna 
is put in contact with the skin, the darker the resulting 
colour will be [3]. As far as allergic reactions are con-
cerned [5, 6], the pure henna is a weak sensitizer and it 
is poorly responsible for allergic contact dermatitis [7–9], 
but when para-phenylenediamine (PPD), that is a strong 
sensitizing agent, is added the frequency of allergic reac-
tions increases. PPD is responsible for professional con-
tact hypersensitivity in photographers, hairdressers and 
workers manipulating rubber components [10]. PPD 
can induce different types of hypersensitivity reactions, 
which may be framed from different points of view, 
according to the time-pattern onset or according to their 
morphological aspects.
Methods
We reviewed the available literature concerning the clini-
cal presentations, the morphological pictures associated 
to allergy to black henna and the immunological mecha-
nisms underlying the allergic reactions.
Results
Clinical manifestations related to a time‑pattern onset
Generally, the first signs of allergic contact dermatitis 
caused by black henna tattoos develop within 1–3 days in 
those already sensitized, and within 4–14 days in patients 
who become sensitized by the tattoo [5]. In 2002 Chung 
et  al. suggested that patients sensitized to black henna 
tattoo should be divided into 2 groups according to their 
clinical course, that may be acute or subacute. This classi-
fication was based on the previous studies of Buckley on 
photographers [11].
Thus, the clinical features define 2 groups: an acute 
response to temporary tattooing, typically presenting 
with intense eczematous responses within 1–2  days of 
tattooing, and a subacute response, that is, developing 
lichenoid eruptions slowly in 1–2 weeks [11].
Some reactions may appear 45 days later following the 
henna tattoo application [12], but sometimes cutaneous 
reactions may appear few hours following henna tattoo 
[13, 14]. The latter possibility is caused by a pre-existing 
sensitization to PPD, probably due to a hidden exposure 
to cross-reactive compounds belonging to the para-
amino group substances [15].
For this reason, beyond the 2 groups identified by 
Chung et  al. there is a third group of patients, whose 
symptoms onset occurs few hours after a clear exposure 
to PPD. Their clinical history often includes a previ-
ous black henna tattoo, performed months or years ago, 
which behaves like a silent promoter of sensitization to 
PPD.
In patients with a silent sensitization to PPD, localized 
cutaneous manifestations are usually represented by a 
severe inflammatory dermatitis leading to skin ulcera-
tions following a further henna tattoo [14, 15], but even 
by a contact urticaria [16] or a contact anaphylaxis due to 
henna tattoo [17] or henna hair dye [18].
Such clinical expressions are based on a IgE-mediated 
reaction to vegetable components of henna, and particu-
larly specific IgE towards a 25  kDa henna protein have 
been detected by immunoblotting [19]. However, when 
applied as a hair dye, PPD alone with no henna compo-
nents has been responsible for immediate-type contact 
anaphylaxis [20–22] or for delayed-type anaphylactic 
reaction [23], rarely even with a fatal outcome [24].
Another kind of hypersensitivity reactions to PPD is 
represented by a severe facial angioedema, appearing 
few hours after a dark hair painting in patients who have 
previously performed a black henna tattoo [25–27]. This 
is an acute, severe and even life-threatening condition, 
sometimes requiring an admission in an Intensive Care 
Unit [25, 28, 29], because of the involvement of the upper 
airways frequently in young patients [30–32].
Interestingly, people poisoned by PPD ingestion for 
suicidal purposes [33, 34] or intoxicated by an exten-
sive black henna tattoo application [35, 36] or by a hair 
dye [36, 37] show clinical signs of rhabdomyolysis, ane-
mia and acute renal failure always associated to a severe 
angioneurotic oedema of the upper airway accompanied 
by a swollen, dry, hard, and protruding tongue.
Morphological clinical pictures
As far as morphological clinical pictures are concerned, 
they appear to be more various and heterogeneous than 
time-pattern contact allergy manifestations (Table  1). 
Thus, beyond the aforementioned urticaria and angi-
oedema or contact anaphylaxis related to black henna 
tattoo painting and the classical eczematous contact der-
matitis [38, 39], have been described lichenoid eruptions 
[11, 40, 41], lymphomatoid reactions [42, 43], vesicular-
bullous lesions [44], which may be very painful and inval-
idating [45, 46], and erythema multiforme like eruptions 
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[29, 47]. Sometimes, the localized eruption may become 
generalized and associated to systemic symptoms as fever 
and malaise [50, 51]. Exceptionally, a Sweet syndrome 
[52], Wells syndrome [53, 54], prurigo nodularis [55] 
and connubial contact dermatitis [56, 57] have been also 
described.
It appears obvious that PPD is able to induce different 
clinical and morphological pattern as it happens in T-cell 
mediated drug hypersensitivity reactions [58], although 
PPD is a contact allergen only. Wolkenstein et  al. sug-
gested that detoxification enzymatic pathway defects are 
involved in toxic epidermal necrolysis and other severe 
cutaneous pathogenesis, allowing reactive metabolites 
accumulation for drugs as sulfonamides and anticonvul-
sant [59].
Because keratinocytes exert metabolic activity with two 
N-acetyltransferases (NAT) 1 and 2 (NAT2), isoenzymes 
for PPD in the skin [60], in a further in  vitro investiga-
tion it has been observed that genotyping for NAT1 and 
NAT2 polymorphisms performed in 147 PPD-sensitized 
patients, the rapid acetylator NAT1*10 allele were under-
represented in PPD-sensitive patients compared with 
200 control subjects [61]. Such study suggests PPD slow 
acetylators NAT2 patients are more prone to develop an 
erythema multiforme-like reaction [47–50], i.e. a more 
serious contact allergy, as well as drug induced severe 
cutaneous eruptions are more frequently observed in 
slow acetylators [59]. However, in patients with severe 
cutaneous drug reactions, an expansion of drug specific 
cytotoxic T CD8+  cell subset and infiltration in cuta-
neous lesions has been observed in the immuno-histo-
pathologic specimens [62]; T cells subsets and different 
cytokine patterns are involved in the variability of clinical 
pictures in drug induced hypersensitivity reactions [58].
By comparing the available data, PPD seems to be 
a hapten with a peculiar aspect, because it may behave 
like a systemic drug to elicit a hypersensitivity response. 
Actually, in PPD sensitized patients specific PPD T cell 
clones CD4+  CD8+  secreting Th2 cytokine pattern, as 
IL-4, IL-5, IL-6, IL-8, IL-10, and IL-13, have been identi-
fied and isolated in vitro [63, 64]. This was reported also 
in mice, because PPD-HSA causes a transient activation 
of CD8+  cytotoxic cells only [63]. However, because 
vesicular bullous reactions have been reported in patients 
with contact hypersensitivity to PPD after henna tattoo 
application [44–46] and two other patterns of T cell acti-
vation by PPD have been evidenced in vitro [63], future 
researches should investigate the relationship between 
clinical morphological aspect of PPD contact dermatitis 
and T-cell subsets predominance.
Discussion and conclusions
Henna has been used traditionally for medicinal pur-
poses and as a cosmetic. For medicinal purposes, it has 
been used as a bitter tea for stomach or intestinal prob-
lems, for fever and headache, as a paste to cure ringworm 
or nail fungus, to reduce chafing and prevent blisters and 
to soothe irritated, dry or chapped skin [3]. As a cos-
metic, henna has been used as a hair thickener, as a nail 
colorant and conditioner and as a decorative stain for the 
body. Also, henna has been used as a brown dye for wool, 
cotton, and silk [3]. Moreover, henna has great signifi-
cance in all Eastern wedding traditions, and no wedding 
is complete without drawing floral motifs or geometric 
decorations on the bride’s hands and feet. The increas-
ing use of henna in the 2000s to make temporary tattoos 
raised the issue of allergic reactions.
Actually, as reported above, the pure henna is a weak 
sensitizer, but the addition of PPD to make tattoos darker 
and long-lasting, thus obtaining black henna, using mix-
tures that are often extemporaneously prepared with a 
variety of materials and sources and very variables con-
centrations of PPD resulted in a recent exploit of contact 
sensitization to PPD. In fact, an increased number of 
cases have been reported through temporary henna tat-
too application. Therefore, dermatologists, paediatricians 
and allergists have alerted about the rising frequency of 
black henna contact allergy [5, 6]. We reviewed the vari-
ous clinical patterns related to PPD and henna tattoo to 
investigate the possible link between clinic-morphologi-
cal pictures and the immunological response to PPD and 
henna. The main results may be summarized in a clinical 
expression with different manifestations related to black 
henna containing PPD, and in a spectrum of allergic 
responses including both delayed-type and immediate-
type reactions.
Table 1 Reactions to  black henna tattoo: main clinical 
manifestations and time to onset after the application
Clinical manifestation Time to onset Ref
Eczematous contact dermatitis 1–2 days [11, 49, 50]
Lichenoid eruptions 1–2 weeks [11, 51, 52]
Contact urticaria and angioneurotic 
oedema
Few hours–2 days [19, 33, 34]
Contact anaphylaxis Few hours [20]
Lymphomatoid reactions Few hours–few days [53, 54]
Vesicular-bullous lesions 1–4 days [55, 56]
Erythema multiforme like eruptions 2–14 days [58–60]
Sweet syndrome 3 days [63]
Wells syndrome 3 days [64, 65]
Prurigo nodularis 3 months [66]
Connubial contact dermatitis Few days [67, 68]
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Fadden et  al. had previously demonstrated that the 
allergenic component of PPD accumulates in the skin. 
Hence, intermittent exposure to low concentration of 
PPD may be equivalent to a higher concentration in a 
one-off exposure [65]. Because different studies, per-
formed in USA and in United Arab Emirates, have shown 
that the presence of PPD high concentrations in henna 
dye mixture ranges from 2 to 29.5% measured through 
high performance liquid chromatography method [5, 
66, 67], it is not unusual that a single henna tattoo, per-
formed as a summer caprice, may be sufficient to induce 
a silent or clear PPD sensitization.
Actually, no specific IgE to PPD or any related oxida-
tive product have been identified in vitro, but it has been 
demonstrated that a radio-labelled PPD containing oxi-
dative hair dye applied to human volunteers for 30 min 
is eliminated predominantly (80–90%) by renal excre-
tion, being accumulated in urine [68]. Such study showed 
that there is a systemic absorption of PPD through the 
skin. Goldberg et  al. had previously reported that the 
oxidation product of PPD causing the immediate-type 
reaction is N′N′-bis(4-aminophenyl)-2,5-diamino-1,4-
quinone-dimine [69], also known as Brandowski base 
(BB), although they were unable to produce a suitable 
RAST assay [69]. A further investigation has recently 
shown that, once penetrated in human body, PPD oxida-
tive products bind irreversibly to cysteine at 34 position 
on human serum albumin [63], so turning to a com-
plete antigen, but it is unclear whether IgE are directed 
towards the chemical component only or towards the 
chemically modified albumin which has become immu-
nogenic. Actually, such an IgE-mediated mechanism has 
been described only in ethylene oxide hypersensitivity 
[70].
In suggestive clinical pictures, like the urticarial-angi-
oedema-like contact dermatitis, although the mecha-
nisms appears as an IgE-mediated reaction, actually it is 
an early onset cell-mediated mechanism [26, 27]. It has 
been suggested, from experimental studies on animals, 
that specific T-cells with a Th2 cytokines pattern profile 
specific to PPD could be the effectors cells of delayed 
response [71]. However, in  vitro studies have suggested 
that also in humans there is a recruitments and activation 
of Th2 clones in response to PPD exposure [63].
Padovan et  al., in their studies on hypersensitivity to 
beta-lactams antibiotics, reported that Th1 profile, very 
common in contact allergy, may shift to a Th2 profile 
depending on the hapten concentration [72]. Because 
high concentrations of PPD are present in henna tattoo 
paintings [16, 67], it is possible that PPD contact der-
matitis is mediated by specific Th2 cell clones, secreting 
interleukin (IL)-4 and IL-5. Such a pathomechanism has 
been confirmed in vitro by the study of Jenkinson et all 
[63]. To determine whether PPD–HSA was antigenic, 
these authors assayed the activity of PPD and PPD–HSA 
on T-cell proliferation, using the lymphocyte transfor-
mation test (LTT) and the proliferation and cytokine 
secretion profile of CD4+  , CD8+  , and CD4/8 double-
positive T-cell clones isolated by stimulating T cells from 
the blood of allergic volunteers with PPD or PPD–HSA. 
The investigators confirmed that PPD was active in the 
LTT and that it stimulated CD4+  , CD8+  , and CD4/8 
double-positive T-cell clones with a Th2 profile [63].
Moreover, Pichler et  al. elaborated the “pharmaco-
logical-immune interaction concept” (p-i concept) as 
they found that some drugs like sulfamethoxazole and 
lidocaine can bind directly to the HLA peptide complex 
stimulating T lymphocytes through an HLA restricted 
processing and metabolism independent pathway [73].
Some in vitro studies have confirmed that such immu-
nological model is working not only for drugs, but even 
for some contact allergen like PPD [74]. For this reason, 
in case of direct exposure to high concentration of PPD, 
the immune response may happen through the “p-i con-
cept” pathways, while the presence memory T-cell clones 
CD4+ CD45RO+, previously demonstrated in vitro [38], 
may accelerate the Th2 immune response in patients 
undergoing to hair dye painting [25–32].
However, further studies are needed to investigate 
the relationship between clinical and morphological 
aspects of PPD contact dermatitis and the T-cell subsets 
predominance.
These observations confirm that the pure henna is 
a weak sensitizer poorly responsible for allergic con-
tact dermatitis, while PPD represents a strong sensitiz-
ing agent responsible for contact hypersensitivity. PPD 
can induce hypersensitivity reactions involving various 
pathogenetic mechanisms that are responsible for the 
time-pattern onset and for their morphological aspects.
Abbreviations
PPD: paraphenylenediamine; NAT: N-acetyltransferases.
Authors’ contributions
GC had the idea of the manuscript and was a major contributor in writing 
the manuscript. EDL was the co-contributor in writing the manuscript. BL 
revised the manuscript. SP analyzed the pubmed resources. CI participated in 
coordination and helped to draft the manuscript. LM analyzed the PubMed 
resources. EN was the co-contributor in creating and drafting the manuscript. 
All authors read and approved the final manuscript.
Author details
1 Pneumology and Allergy Department, Hospital Sacro Cuore, Gallipoli, Lecce, 
Italy. 2 Section of Allergy and Clinical Immunology, Unit of Internal Medicine-“F. 
Miulli” Hospital, Acquaviva delle Fonti, Bari, Italy. 3 Department of Pediatrics, 
University of California Davis School of Medicine, Sacramento, USA. 4 Allergy 
Outpatients’ Clinic, ASL-TO3, Ospedale Civile “E. Agnelli”, Pinerolo, Turin, Italy. 
5 ASST Specialistic Center Gaetano Pini/CTO, Milan, Italy. 6 Section of Allergy 
and Clinical Immunology, Department of Internal Medicine and Infectious 
Diseases, University of Bari Medical School, Bari, Italy. 
Page 5 of 6Calogiuri et al. Clin Mol Allergy  (2017) 15:8 
Acknowledgements
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Received: 29 October 2016   Accepted: 2 March 2017
References
 1. Levy J, Sewell M, Goldstein N. Á short history of tattooing. J Dermatol 
Surg Oncol. 1979;5:851–6.
 2. Bauman Z. Liquid modernity. 1st ed. Cambridge: Polity Press; 2000.
 3. Semwal RB, Semwal DK, Combrinck S, Cartwright-Jones C, Viljoen A. 
Lawsonia inermis L. (henna): ethnobotanical, phytochemical and pharma-
cological aspects. J Ethnopharmacol. 2014;155(1):80–103.
 4. Lestringant GG, Bener A, Frossard PM. Cutaneous reactions to henna and 
associated additives. Br J Dermatol. 1999;141:598–600.
 5. de Groot AC. Side-effects of henna and semi-permanent ‘black henna’ 
tattoos: a full review. Contact Dermat. 2013;69:1–25.
 6. Calogiuri G, Foti C, Bonamonte D, Nettis E, Muratore L, Angelini G. Allergic 
reactions to henna-based temporary tattoos and their components. 
Immunopharmacol Immunotoxicol. 2010;32:700–4.
 7. Thami GP, Kaur S, Kanwar AJ. Allergic contact dermatitis to henna. Allergy. 
2001;56:1013–4.
 8. Öztaş MO, Önder M, Öztaş P, Atahan Ç. Contact allergy to henna. J Eur 
Acad Dermatol Venereol. 2001;15:91–2.
 9. Polat M, Dikilitaş M, Oztaş P, Alli N. Allergic contact dermatitis to pure 
henna. Dermatol Online J. 2009;15:15.
 10. DeLeo VA. Contact allergen of the year: paraphenylenediamine. Dermati-
tis. 2006;17:53–5.
 11. Chung WH, Chang YC, Yang LJ, Hung SI, Wong WR, Lin YJ, Chan HL. Clin-
icopathologic features of skin reactions to temporary tattoos and analysis 
of possible causes. Arch Dermatol. 2002;138:88–92.
 12. Pegas JR, Criado PR, Criado RF, Vasconcellos C, Pires MC. Allergic contact 
dermatitis to temporary tattoo by p-paraphenylenediamine. J Invest 
Allergol Clin Immunol. 2002;12:62–4.
 13. Tosti A, Pazzaglia M, Corzza M, Virgili A. Allergic contact dermatitis caused 
by mehindi. Contact Dermat. 2000;42:356.
 14. Ballard MS. Contact dermatitis after henna skin tattooing. J R Army Med 
Corps. 2006;152:242–3.
 15. Arroyo MP. Black henna tattoo reaction in a person with sulphonamide 
and benzocaine drug allergies. J Am Acad Dermatol. 2003;48:301–2.
 16. Temesvari E. Contact urticaria from paraphenylenediamine. Contact 
Dermat. 1984;11:125.
 17. Abdullah K, McDavidson N. A woman who collapsed after painting her 
soles. Lancet. 1996;348:658.
 18. Cronin E. Immediate type hypersensitivity to henna. Contact Dermat. 
1979;5:198–9.
 19. Bolhar ST, Mulder M, van Ginkel CJW. IgE mediated allergy to henna. 
Allergy. 2001;56:248.
 20. Mavrolein G, Begishvili B, Frew AJ. Anaphylaxis to hair dye: a case report. 
Clin Exp Allergy. 1998;28:121–2.
 21. Fukunaga T, Kawagoe R, Hozumi H, Kanzaki T. Contact anaphylaxis due to 
paraphenylenediamine. Contact Dermat. 1996;35:185–6.
 22. Pasche-Koo E, French L, Piletta-Zanin PA, Hauser C. Contact urticarial and 
shock to hair dye. Allergy. 1998;53:904–5.
 23. Sahoo B, Handa S, Penchalla K, Kumab H. Contact anaphylaxis due to hair 
dye. Contact Dermat. 2000;43:244.
 24. Belton AL, Chira T. Fatal anaphylactic reaction to hair dye. Am J Forensic 
Med Pathol. 1997;18:290–2.
 25. Shavit I, Hoffmann Y, Shachor-Meyouhas Y, Knaani-Levinz H. Delayed 
hypersensitivity reaction from black henna tattoo manifesting as severe 
facial swelling. Am J Emerg Med. 2008;26:515e3–4.
 26. Gulen F, Zeyrek D, Altinoz S, Perer E, Demir E, Tanac R. Urticaria and 
angioneurotic edema due to the temporary henna tattoo. Minerva Ped. 
2006;58:583–5.
 27. Tukenmez Demirci G, Kivanc Altunay I, Atis G, Kucukunal A. Allergic con-
tact dermatitis mimicking angioedema due to paraphenylenediamine 
hypersensitivity: a case report. Cutan Ocul Toxicol. 2011;31:1–3.
 28. Jasmin ZF, Darling JR, Handley JM. Severe allergic contact dermatitis to 
paraphenylenediamine in hair dye following sensitization to black henna 
tattoos. Contact Dermat. 2005;52:116–7.
 29. Broides A, Sofer S, Lazar I. Contact dermatitis with severe scalp swelling 
and upper airway compromise due to black henna hair dye. Pediatr 
Emerg Care. 2011;27:745–6.
 30. Kind F, Scherer K, Bircher AJ. Contact dermatitis to paraphenylenediamine 
in hair dye following sensitization to black henna tattoos: an ongoing 
problem. J Deuscht Dermatol Gesel. 2012;10:572–7.
 31. Redlick F, DeKoven J. Allergic contact dermatitis to paraphenylenedi-
amine in hair dye after sensitization from black henna tattoos: a report of 
6 cases. Can Med Assoc J. 2007;176:445–6.
 32. Sosted H, Johanssen JD, Andersen KE, Menné T. Severe allergic hair dye 
reaction in 8 children. Contact Dermat. 2008;54:87–91.
 33. Suliman SM, Homeida M, Aboud OI. Paraphenylenediamine induced 
acute tubular necrosis following hair dye ingestion. Hum Toxicol. 
1983;2:633–5.
 34. D’Arcy PF. Fatalities with the use of henna dye. Pharm Intern. 
1982;3:217–8.
 35. Hashim M, Hamza YO, Yahia B. Poisoning from henna dye and para-
phenylenediamine mixtures in children in Karthoum. Ann Trop Pediatr. 
1992;12:3–6.
 36. Brown JH, Conway B, Hill CM. Chronic renal faiure associated with topical 
application of paraphenylenediamine. Br J Med. 1987;294:155.
 37. Abdelraheem MB, El-Tigani MA, Hassan EG, Ali MA, Mohamed IA, Nazik 
AE. Acute renal failure owing to paraphenylene diamine hair dye poison-
ing in Sudanese children. Ann Trop Paediatr. 2009;29:191–6.
 38. Le Coz CJ, Lefebvre C, Keller F, Grosshans E. Allergic contact dermatitis 
caused by skin painting (pseudotattooing) with black henna, a mixture 
of henna and p-phenylenediamine and its derivatives. Arch Dermatol. 
2000;136:1515–7.
 39. Jovanovic DL, Slavkovic-Jovanovic MR. Allergic contact dermatitis from 
temporary henna tattoo. J Dermatol. 2009;36(1):63–5.
 40. Rubegni P, Fimiani M, de Aloe G, Andreassi L. Lichenoid reaction to tem-
porary tattoo. Contact Dermat. 2000;42:117–8.
 41. Sharma VK, Mandal SK, Sethuraman G, Bakshi NA. Para-phenylenedi-
amine-induced lichenoid eruptions. Contact Dermat. 1999;41:40–1.
 42. Calzavara-Pinton P, Capezzera R, Zane C, Brezzi A, Pasolini G, Ubiali A, et al. 
Lymphomatoid allergic contact dermatitis from para-phenylenediamine. 
Contact Dermat. 2002;47:173–4.
 43. Paley K, Geskin LJ, Zirwas MJ. Cutaneous B-cell pseudolymphoma due to 
paraphenylenediamine. Am J Dermatopathol. 2006;28:438.
 44. Choovichian V, Chatapat L, Piyaphanee W. A Bubble Turtle: bullous 
contact dermatitis after a black henna tattoo in a backpacker in Thailand. 
J Travel Med. 2015;22:287–8.
 45. Jung P, Seszttak-Greinecker G, Wantke F, Gotz M, Jarisch R, Hemmer W. A 
painful experience: black henna tattoo causing severe bullous contact 
dermatitis. Contact Dermat. 2005;54:219–20.
 46. Van den Keybus C, Morren MA, Goossens A. Walking difficulties due to an 
allergic reaction to a temporary tattoo. Contact Dermat. 2008;53:180–1.
 47. Barrientos N, Abajo P, de Vega MM, Dominguez J. Erythema multiforme-
like eruption following allergic contact dermatitis in response to 
para-phenylenediamine in a temporary henna tattoo. Int J Dermatol. 
2014;53:348–50.
 48. Jappe U, Hausen BM, Petzoldt D. Erythema-multiforme-like eruption and 
depigmentation following allergic contact dermatitis from a paint-on 
henna tattoo, due to para-phenylenediamine contact hypersensitivity. 
Contact Dermat. 2001;45:249–50.
 49. Sidwell RU, Francis ND, Path FRC, Basarab T, Morar N. Vescicular erythema 
multiforme like reaction to paraphenylenediamine in a henna tattoo. 
Pediat Dermatol. 2008;25:201–4.
 50. Neri I, Giacomini F, Raone B, Patrizi A. Generalized erythema multiforme 
after localized allergic dermatitis from dark henna tattoo. Pediatr Derma-
tol. 2009;26:496.
 51. Mohamed M, Nixon R. Severe allergic contact dermatitis induced by 
paraphenylenediamine in paint-on temporary tattoos. Australas J Derma-
tol. 2000;41:168–71.
Page 6 of 6Calogiuri et al. Clin Mol Allergy  (2017) 15:8 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 52. Rosmaninho A, Machado S, Amorim I, Lobo I, Selores M. Henna tattoo 
and Sweet syndrome: a possible relation. Eur J Dermatol. 2009;19:642–3.
 53. Nacaroglu HT, Celegen M, Karkıner CS, Günay I, Diniz G, Can D. Eosino-
philic cellulitis (Wells’ syndrome) caused by a temporary henna tattoo. 
Postepy Dermatol Allergol. 2014;31:322–4.
 54. Lönngren V, Young E, Simanaitis M, Svedman C. Neutrophilic and eosino-
philic dermatitis caused by contact allergic reaction to paraphenylenedi-
amine in hair dye. Arch Dermatol. 2012;148:1299–301.
 55. Verma P, Yadav P. Paraphenylenediamine dye allergic contact dermatitis 
of mustache region manifesting as prurigo nodularis-like lesions. Derma-
titis. 2014;25:91–2.
 56. Lopez IE, Turrentine JE, Cruz PD. Clues to diagnosis of connubial contact 
dermatitis to paraphenylenediamine. Dermatitis. 2014;25:32–3.
 57. Goldenberg A, Matiz C, Eichenfield LF. Religious allergic contact dermati-
tis. Pediatr Dermatol. 2015;32:191–2.
 58. Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D. Drug hyper-
sensitivity reactions: pathomechanism and clinical symptoms. Med Clin 
North Am. 2010;94:645–64.
 59. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Meta-
bolic predisposition to cutaneous adverse drug reactions. Role in toxic 
epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch 
Dermatol. 1995;131:544–51.
 60. Kawakubo Y, Merk HF, Masaoudi TA, Sieben S, Blömeke B. N-Acetylation 
of paraphenylenediamine in human skin and keratinocytes. J Pharmacol 
Exp Ther. 2000;292:150–5.
 61. Blömeke B, Brans R, Coenraads PJ, Dickel H, Bruckner T, Hein DW, et al. 
Para-phenylenediamine and allergic sensitization: risk modification by 
N-acetyltransferase 1 and 2 genotypes. Br J Dermatol. 2009;161:1130–5.
 62. Rozieres A, Vocanson M, Saïd BB, Nosbaum A, Nicolas JF. Role of T cells in 
non-immediate allergic drug reactions. Curr Opin Allergy Clin Immunol. 
2009;9:305–10.
 63. Jenkinson C, Jenkins R, Aleksic M, Pirmoahamed M, Naisbit D, Park BK. 
Characterization of para-phenylenediamine-albumin binding sites 
and T-cell responses to hapten modified protein. J Investig Dermatol. 
2010;110:732–42.
 64. Coulter EV, Jenkinson C, FarrellJ Lavergne SN, Pease C, White A, et al. 
Measurement of CD4þ and CD8þ T-lymphocyte cytokine secretion and 
gene expression changes in para- phenylenediamine allergic patients 
and tolerant individuals. J Investig Dermatol. 2010;130:161–74.
 65. White J, Basketter D, Pease C, Sanders D, McFadden J. Intermittent expo-
sure to low concentration paraphenylenediamine can be equivalent to 
single higher-dose exposure. Contact Dermat. 2007;56:262–5.
 66. Brancaccio RR, Brown LH, Chang YT, Fogelman JP, Mafong EA, Cohen DE. 
Identification and quantification of para-phenylenediamine in a tempo-
rary black henna tattoo. Am J Contact Dermat. 2002;13:15–8.
 67. Al Suwaidi A, Ahmed H. Determination of paraphenylenediamine (PPD) 
in henna in the United Arab Emirates. Int J Environ Res Public Health. 
2010;7:1681–93.
 68. Hueber-Becker F, Nohyneck G, Meuling W, Beneech-Keffer F, Toutain H. 
Human systemic exposure to a 14-C-paraphenylenediamine containing 
oxidative hair dye and correlation with in vitro percutaneous absorption 
in human or pig skin. Food Chem Toxicol. 2004;42:1227–36.
 69. Goldberg JB, Herman FF, Hirata I. Systemic anaphylaxis due to an 
oxidation product of para-phenylenediamine in hair dye. Ann Allergy. 
1987;7:38–40.
 70. Grammer LC, Paterson BF, Roxe D, Daugirdas JT, Ing TS, Ivanovich PT, 
et al. IgE against ethylene oxide-altered human serum albumin in 
patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol. 
1985;7:511–4.
 71. Yokozeki H, Wu MH, Sumi K, Igawa Y, Miyazaki Y, Katayama I, et al. Th2 
cytokines, IgE and mast cells play a crucial role in the induction of para-
phenylenediamine induced contact hypersensitivity in mice. Clin Exp 
Immunol. 2003;132:385–92.
 72. Padovan E, von Greyerz S, Pichler WJ, Weltzien HU. Antigen-dependent 
and -independent IFN-gamma modulation by penicillins. J Immunol. 
1999;162:1171–7.
 73. Zanni M, von Greyter S, Schneyder B, Wendland T, Pichler WJ. Allele unre-
stricted presentation of lidocaine by HLA DR molecules to alpha/beta+ T 
cells clones. Int Immunol. 1998;10:507–15.
 74. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blomeke B. Delayed type 
hypersensitivity reaction to para-phenylenediamine is mediated by 2 
different pathways of antigen recognition by specific alpha/beta human 
T cell clones. J Allergy Clin Immunol. 2002;109:1003–11.
